MYX 2.39% $4.50 mayne pharma group limited

Analyst price targets after market update, page-20

  1. 3,053 Posts.
    lightbulb Created with Sketch. 2
    May and June are 16.7% of the year. On 1 May they said they were going to hit guidance, but they missed by 4%. That's a 24% miss at the EBITDA level for those months. Further they have raised their guidance for their tax rate, and they have around $250m of debt, leveraging that impact. TEVA/MYL/MNK/ENDP continue to spiral down. That's why CS cut their NPAT estimates by 30%, and MYX has now gone from a growth stock to a negative growth stock.

    The brokers were incompetent in not cutting their forecasts earlier on the obvious problems with MYX's business models, their revisions just reflect the scales falling from their eyes - perhaps you should revisit some of your assumptions and see if you still hold the same view.

    Either way, I'm done for now, good luck.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$4.50
Change
-0.110(2.39%)
Mkt cap ! $382.8M
Open High Low Value Volume
$4.60 $4.64 $4.39 $669.1K 147.9K

Buyers (Bids)

No. Vol. Price($)
1 2465 $4.50
 

Sellers (Offers)

Price($) Vol. No.
$4.53 1104 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.